Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
Rats pretreated with tranylcypromine and given clomipramine, developed head and body twitches, forelimb flexor-extensor movements and wet dog shakes, phenomena which failed to develop when pretreatment incorporated p-chlorophenylalanine (PCPA) but were unabated when this included alpha-methyl-p-tyrosine (AMPT). Locomotor activity, itself enhanced by tranylcypromine, was further and significantly elevated compared to saline, by clomipramine or imipramine in grouped rats (n = 3) but not in single or paired rats; desipramine lacked such action. This effect of clomipramine was prevented when PCPA was incorporated into the pretreatment and that of imipramine by including PCPA or AMPT. Brain monoamine oxidase (MAO) A inhibition was 92% and that of MAO B, 80%. Cortical hydroxytryptamine (5-HT) and noradrenaline concentrations as well as hypothalamic 5-HT, were significantly elevated by tranylcypromine, as was dopamine in the striatum, nucleus accumbens and tuberculum olfactorium. Hyperthermia developed in tranylcypromine pretreated rats given paroxetine or fluoxetine. Myoclonic phenomena were elicited by paroxetine, fluoxetine, clomipramine or imipramine in nialamide pretreated rats but these were less intense than in rats pretreated with phenelzine or tranylcypromine. Fatalities were fewer than in rats pretreated with tranylcypromine or phenelzine. Brain MAO A inhibition was 92% and that of MAO B, 69%.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects; D018492:Dopamine Antagonists; D004347:Drug Interactions; D010134:Fenclonine / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009207:Myoclonus / Q000139:chemically induced; D009526:Nialamide / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D051381:Rats; D012702:Serotonin Antagonists / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology*; D019805:alpha-Methyltyrosine
D000929:Antidepressive Agents, Tricyclic; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D012702:Serotonin Antagonists; D014191:Tranylcypromine; D019805:alpha-Methyltyrosine; D010134:Fenclonine; D009526:Nialamide; D009638:Norepinephrine